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PRODUCTION OF 3D SCAFFOLDS FROM NATURAL POLYMERS AND 
THEIR CHARACTERISATION 
SUMMARY 
Composite 3D scaffolds with different blending ratios of silk fibroin and gelatin as 
natural polymers were produced by freeze-drying method within the scope of this 
study. The total polymer ratio of the scaffolds was 4% (w/v) and they were named 
based on their polymer contents as follows: 4% (w/v) silk fibroin, 3% (w/v) silk 
fibroin-1% (w/v) gelatin, 2% (w/v) silk fibroin-2% (w/v) gelatin, 1% (w/v) silk 
fibroin-3% (w/v) gelatin and 4% (w/v) gelatin being F4-G0, F3-G1, F2-G2, F1-G3 
and F4-G0, respectively. According to the SEM images of these samples, F3-G1, F2-
G2 and F1-G3 composite scaffolds had homogeneous porous structures and therefore 
selected for water-uptake and 3-day in vitro biodegradation test that was studied with 
three different enzyme concentrations (0.05, 0.1 and 0.2 U/mL). They were also 
treated with methanol and their FTIR spectra showed that this treatment led to β-
sheet formation in F3-G1 and F2-G2 samples. 
Once the three scaffold groups were immersed in PBS solution, the F2-G2 samples 
exhibited the highest water-uptake capacity (1271%), which was 797% and 1053% 
for F3-G1 and F1-G3 samples, respectively. The F1-G3 samples, which comprised 
the highest gelatin content, had the highest degradation rate at all enzyme 
concentrations tested for the 3-day biodegradation assay, whereas the F3-G1 samples 
had the lowest degradation ratio in all cases. The F2-G2 samples showed similar 
behaviour with F3-G1 sample except the one with the highest enzyme concentration 
in which an accelerated degradation was observed. As a result, the F3-G1 and F2-G2 
samples and the enzyme concentration of 0.05 U/mL were selected for the main 28-
day biodegradation test. 
The average remaining weight ratio of the F3-G1 and F2-G2 samples was 50% and 
42%, respectively, at the end of the 28-day biodegradation test. The degradation rate 
of the F3-G1 samples was lower than that of the F2-G2 samples during the first 7 
days of the test. At the end of the 2
nd
 week, the average remaining weight percentage 
was almost the same for all samples. Additionally, the SEM images of almost all 
degraded samples showed more porous structures indicating bulk erosion.  
In order to induce hydroxyapatite formation on the surfaces of the samples, the F3-
G1 and the F2-G2 scaffolds were immersed in either 1x or 3x mSBF for different 
time intervals of 1, 4 and 7 days. The SEM images of the F3-G1 samples showed no 
hydroxyapatite formation, except the one treated with 1x mSBF and collected after 
the 1
st
 day. For F2-G2 samples, only the SEM images of the ones treated with 1x or 
3x mSBF and collected after the 4
th
 day did not exhibit any hydroxyapatite crystals. 
On the other hand, some absorption peaks that are characteristic to the some 
chemical groups of hydroxyapatite crystals were detected in the FTIR spectra of the 
all F3-G1 and F2-G2 samples that may be formed due the hydroxyapatite formation 
on the surfaces of the scaffolds.    
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DOĞAL POLİMERLER İLE HAZIRLANAN DOKU İSKELELERİNİN 
YAPIMI VE KARAKTERİZASYONU 
ÖZET 
Yaralanmalar, kazalar ve hastalıklar nedeniyle organ veya dokularda meydana gelen 
hasarlar veya iĢlevsel yetmezlikler dünya genelinde birçok insan için büyük bir sorun 
teĢkil etmektedir. Bu noktada, doku mühendisliği, biyoloji, kimya ve mühendislik 
ilkelerinden faydalanarak özellikle kemik, kıkırdak, karaciğer ve deri dokularında 
meydana gelen hasarların iyileĢtirilmesi amacıyla mevcut geleneksel tedavi 
yöntemlerine ek olarak yeni tedavi fırsatları sunmaktadır. Transplantasyon için 
uygun otolog ve allojenik dokuların eksikliği ve sentetik dokuların 
biyouyumluluğunun düĢük olması yerleĢik tedavi seçenekleri arasında görülen 
baĢlıca sorunlardan olup hastalıkların hızlı progresyonu, uygun bağıĢçıların 
bulunamaması ve pahalı medikal uygulamalar da bu tedavilerin dezavantajları 
arasında gösterilmektedir. Bu gibi nedenlerden ötürü kısmen veya tamamen 
kaybedilmiĢ veya zarar görmüĢ organ veya dokuların iĢlevsel olanlar ile 
değiĢtirilmesi için yeni teknolojiler geliĢtirilmesi modern rejeneratif tıbbın odak 
noktaları arasında yer almaktadır.  
Yeni yapay dokuların oluĢturulması amacıyla doku mühendisliği, farklı özellikteki 
biyomalzemeleri kullanarak doku iskelesi (“scaffold”) adı verilen, yeni dokuların 
oluĢması ve geliĢmesi için uygun bir mikroçevre ve histolojik organizasyon sağlayan 
üç boyutlu yapıların üretilmesini sağlamaktadır. Hücre bağlanması, çoğalması, 
farklılaĢması ve üç boyutlu doku oluĢumu için uygun yüzey kimyasına ve yapısına 
sahip olması gereken doku iskeleleri için seçilen biyomalzemelerin hedef doku 
özelliklerine özgü bir Ģekilde seçilmesi ve kullanılması doku mühendisliği 
uygulamalarının baĢarısı için büyük önem taĢımaktadır. Ayrıca, büyüme faktörleri 
gibi biyolojik moleküllerin doku iskelelerine katılması ile doku iskelelerinin hücre 
aktivitelerini istenildiği Ģekilde yönlendirme yeteneği de iyileĢtirilebilmektedir. Doku 
mühendisliğinin üç temel unsuru olan doku iskelesi, biyolojik moleküller ve 
hücreler, uygulamalardan elde edilen sonuçlar üzerinde büyük rol oynamaktadır. Bu 
üç unsur arasında ise doku iskeleleri, yeni doku oluĢumun her bir aĢamasında 
baĢından sonuna dek yer aldığından ayrıca dikkati çekmektedir. 
Biyomalzeme olarak adlandırılan; sentetik polimer, metal, alaĢım veya seramik 
formunda laboratuvarda üretilen sentetik malzemelerin veya doğal polimerlerin 
kullanılması ile üretilen doku iskeleleri, sundukları yapısal, mekanik ve biyolojik 
özelllikler nedeniyle doku mühendisliği uygulamaları için her geçen gün daha fazla 
önem kazanmaktadır. Hücrelerin metabolik iĢlevleri için gerekli besin maddelerinin 
sağlanması ve metabolik aktiviteler sonucu ortaya çıkan atıkların uzaklaĢtırılması 
için uygun mikroçevreyi sağlaması gereken doku iskelelerinin birbiri ile bağlantılı ve 
toplam yüzey alanını artıran gözenekelere sahip olması; doğal dokununkine yüksek 
oranda benzeyen ekstraselüler matriks oluĢumu, hücre bağlanması, çoğalması ve 
farklılaĢması için uygun altyapıyı sunması; yeni doku oluĢumuna dek doku iĢlevsel 
ve mekanik özelliklerini koruması gerekmektedir. 
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Polimer, metal ve seramik gibi malzemeler doku iskelelerinin üretilmesi amacıyla 
yaygın olarak kullanılmaktadır. Birçok klinik araĢtırmanın odak noktası olan sentetik 
ve doğal polimerlerin kendi içlerinde sunduğu farklı avantajlar ve dezavantajlar 
bulunmaktadır. Sentetik polimerler kolayca iĢlenebilip değiĢtirilebilirken doğal 
polimerler yüksek biyouyumluluk sağlamaktadır. Öte yandan, farklı doku tipleri 
farklı fiziksel, mekanik ve degradasyon özellikleri gerektirdiğinden tüm doku 
tiplerine yönelik olarak kullanılabilecek tek bir biyomalzeme tipi bulunmamaktadır. 
Doku iskelelerinin üretiminde kullanılan doğal polimerlerden olan ipek fibroini, 
yüksek oksijen geçirgenliği, biyouyumluluğu, kontrol edilebilir biyodegradasyonu ve 
mekanik özellikleri nedeniyle yapay kan damarları, ameliyat iplikleri gibi 
biyomedikal amaçlı uygulamalarda kullanım için FDA tarafından onaylanmıĢ bir 
biyomalzeme olup doku mühendisliği uygulamaları çerçevesinde fibroblastlar, 
osteoblastlar ve hepatositler için uygun bir yapısal destek malzemesidir. 
Bir baĢka doğal polimer olan jelatin, kollajenin hidrolize edilmesi ile elde 
edilmektedir. Biyouyumluluğu, biyodegradasyon özelliği ve düĢük maliyeti 
nedeniyle ilaç, medikal ve gıda sanayilerinde sıkça kullanılmakta olan jelatin düĢük 
mekanik dayanıklılığı sebebiyle doku mühendisliği uygulamaları için farklı 
malzemeler ile kombinasyon halinde uygulanmaktadır.     
Hedef doku tipi ve özelliklerine bağlı olarak istenilen yapısal, kimyasal ve biyolojik 
özelliklere sahip doku iskelelerinin üretilmesi için farklı yöntemlerden 
yararlanılmaktadır. Dondururarak kurutma, tuz giderme, gaz köpürtme ve 
elektroçekme yöntemleri doku mühendisliği uygulamaları kapsamında yaygın olarak 
kullanılan yöntemlerdir.  
Liyofilizasyon olarak da adlandırılan dondurarak kurutma yöntemi süblimleĢme 
temeline dayanan iki aĢamalı bir kurutma iĢlemi olup doku iskelesi üretimi için 
hazırlanmıĢ örnekten dondurulmuĢ çözücünün, çoğunlukla suyun, uzaklaĢtırılmasını 
sağlamaktadır. Bir malzemenin dondurularak kurutulması için önce dondurulması 
ardından da dondurulmuĢ sıvının yüksek vakumlu ortamda süblimleĢmesi ve 
böylelikle yalnızca kurumuĢ bileĢenleri geride bırakması gerekmektedir. Kurumakta 
olan yüz ile yoğunlaĢtırıcı arasında proses sırasında oluĢan konsantrasyon gradiyenti 
liyofilizasyondaki sıvının uzaklaĢtırılması için itici güç görevi görmektedir. Sıvı 
kristalleri, örnek için hazırlanmıĢ çözelti tamamen deriĢik duruma gelene dek 
çözeltiden ayrılmaya devam etmektedir. Doku iskeleleri için önemli parametreler 
olarak bilinen gözenek büyüklüğü ve gözenek alanı liyofilizasyon süresi ve sıcaklığı 
değiĢtirilerek ayarlanabilmektedir. Basit ve kolay olmasına karĢın dondurarak 
kurutma yöntemi zaman ve enerji tüketimi açısından dezavantajlı da olabilmektedir.   
Bu çalıĢma, kemik dokusunda meydana gelen hasarların onarılmasını ve kemik doku 
yenilenmesini sağlayan biyouyumlu, biyobozunur, doğal polimerik yapıya sahip ve 
doğal kemik yapısına benzeyen üç boyutlu doku iskelesi üretimini ve 
karakterizasyonunu amaçlamaktadır. Bu amaçla, ipek böceği kozalarından elde 
edilen ipek fibroini ile ticari olarak temin edilen jelatinin farklı oranlardaki 
kombinasyonu ile doku iskeleleri üretilmiĢ, üretilen bu iskeleler yapısal olarak 
incelenmiĢ ve su tutma, biyobozunma ve biyomineralizasyon testlerine tabi 
tutulmuĢtur. 
Ġpek fibroin/jelatin oranları 100/0, 75/25, 50/50, 25/75 ve 0/100 olan ve sırasıyla F4-
G0, F3-G1, F2-G2, F1-G3 ve F0-G4 olarak adlandırılan doku iskelelerinin 
morfolojileri Taramalı Elektron Mikroskobu (Scanning Electron Microscopy, SEM) 
ile incelenmiĢtir. Bu incelemere göre, kompozit örneklerdeki jelatin oranı arttıkça 
örneklerin yüzey yapılarının gözenekliliğinin arttığı ve örneklerin homojen gözenekli 
bir yapı sergiledikleri görülmüĢtür. F4-G0 örnekleri ayrı katmanlı yapılara sahipken 
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F0-G4 örnekleri ise homojen gözeneklilik açısından diğer örneklere üstünlük 
sağlamıĢtır. Kompozit örnekler arasında en iyi gözenekli yapıyı F1-G3 örnekleri 
göstermiĢken bu incelemelere dayanarak F3-G1, F2-G2 ve F1-G3 örnekleri, homojen 
gözenekli yapıları ve genel morfolojileri nedeniyle, metanolün örneklerin kimyasal 
yapısı üzerindeki etkiyi gözlemlemek amacıyla Fourier Transform Infrared (FTIR) 
Spektroskopisi ile incelenmiĢ ve ayrıca su tutma ve 3 günlük biyodegradasyon 
testlerine tabi tutulmuĢtur.  
FTIR Spektroskopisi sonuçlarına göre örneklerin metanol ile muamele edilmesi F3-
G1 ve F2-G2 örneklerinin ikincil yapılarında β tabakası oluĢumundan 
kaynaklanabilecek kısmi değiĢikliğe neden olurken F1-G3 örneklerinde ise bir 
değiĢiklik görülmemiĢtir. Üç kompozit doku iskelesi arasında en yüksek su tutma 
oranı %1271 ile F2-G2 örneklerinde görülürken bu oran F3-G1 ve F1-G3 örnekleri 
için sırasıyla %797 ve %1053 olmuĢtur. Üç farklı enzim konsantrasyonu (0,05, 0,1 
ve 0,2 U/mL) ile gerçekleĢtirilen üç günlük biyobozunma testleri, jelatin oranı ve 
enzim konstrasyonu arttıkça kompozit doku iskelelerinde görülen bozulma oranının 
da arttığını göstermiĢtir. 3 günlük deneyden elde edilen sonuçlar değerlendirildiğinde 
asıl biyobozunma çalıĢmasının 28 gün süreceği göz önüne alındığında, bu çalıĢma 
için F3-G1 ve F2-G2 örneklerinin seçilmesi ve enzim deriĢiminin 0,05 U/mL olması 
kararlaĢtırılmıĢtır. 
F3-G1 ve F2-G2 örneklerinin 28 gün süren biyobozunma testi sonunda jelatin oranı 
yüksek olan F2-G2 örneklerinde %58 oranında bozulma görülürken bu oran F3-G1 
örnekleri için %50 olarak kaydedilmiĢtir. Bununla birlikte, testin ilk 7 günü süresince 
F2-G2 örneklerinde F3-G1 örneklerine kıyasla daha hızlı bir bozunma gözlemlenmiĢ, 
14 gün sonunda ise tüm örnekler için bozunma sonrası geriye kalan ortalama örnek 
ağırlığı oranı hemen hemen aynı olmuĢtur. Testin 7., 14., 21. ve 28. günleri sonunda 
alınan örneklerin morfolojileri ise genel olarak test öncesindeki morfolojilerinden 
farklılık göstermiĢ, örnek yapısı daha gözenekli bir hal almıĢtır. 
F3-G1 ve F2-G2 örnekleri için ayrıca 7 gün süren bir biyomineralizasyon testi 
uygulanmıĢtır. Bu test ile örnekler 1x ve 3x olmak üzere iki farklı deriĢimdeki 
değiĢtirilmiĢ yapay vücut sıvısı (modified simulated body fluid, mSBF) ile muamele 
edilmiĢ ve kemik dokusunun önemli bir kısmını teĢkil eden hidroksiapatit oluĢumu 
testin 1., 4. ve 7. günü sonunda alınan örnekler için SEM ve FTIR Spekroskopisi ile 
incelenmiĢtir. SEM sonuçlarına göre, F3-G1 örneklerinin tümü için yalnızca 1x 
mSBF ile muamele edilen 1. gün örneklerinde hidroksiapatit oluĢtuğu görülmüĢ, F2-
G2 örneklerinde ise her iki deriĢimdeki mSBF için 4. gün örnekleri hariç tüm 
örneklerde hidroksipatit oluĢumu meydana gelmiĢtir. Biyomineralizasyon testinin 
daha iyi değerlendirilebilmesi için örneklerin FTIR spektrumlarının incelenmesiyle 
hidroksiapatit oluĢumu için karakteristik kimyasal gruplara ait absorpsiyon bantları 
her iki mSBF deriĢiminde de F3-G1 ve F2-G2 örnekleri için görülmüĢ ve bu durum 
biyomineralizasyonun gerçekleĢmesi olarak yorumlanmıĢtır.   
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1.  INTRODUCTION 
1.1 Purpose of Thesis 
Tissue and organ defects or failures because of injuries, accidents or other damages 
are a major health problem for many people worldwide. At this point, tissue 
engineering emerges as an expanding field of applied biology and biomedical 
engineering making use of chemistry, biology and engineering principles in order to 
create new treatment opportunities to existing conventional interventions for 
damages of bone, cartilage, liver or skin tissues. 
In order to produce new artificial tissues, tissue engineering uses biomaterials to 
construct three-dimensional templates, called scaffolds, which serve as an 
environment necessary for complete tissue formation and development. These 
scaffolds need to possess a surface chemistry and structure enabling cell attachment, 
proliferation, differentiation and 3D tissue formation. For this reason, designing 
appropriate biomaterials specific to properties of tissue of interest play an important 
role in the success of tissue engineering approaches. Additionally, biological 
molecules such as growth factors can be incorporated into scaffolds to improve the 
construct’s capability to direct activities of seeded cells. Each of three major 
components of tissue engineering, scaffolds, bioactive molecules and cells, have 
significant effects on the outcomes of this field.  
In the current study, a biocompatible and biodegradable 3D scaffold was fabricated 
using a blend of two different natural polymers, silk fibroin and bovine gelatin for 
bone tissue regeneration and repair. For this purpose, silk fibroin extracted from 
Bombyxmori silk worm cocoons and bovine gelatin purchased from a commercial 
supplier were used in different concentrations and the resultant scaffolds were 
subjected to water-uptake, biodegradation and biomineralisation  tests in order to 
compare and evaluate the effect of blending ratios on the behaviour of scaffolds.  
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1.2 Tissue Engineering 
Loss or failure of an organ and tissue as a result of an injury, disease or any kind of 
damage is a major health problem that many people are suffering from [1, 2]. 
Hurdles in early therapies centred on the lack of autologous and allogenic tissues 
suitable for transplantation and poor biocompatibility of synthetic tissue for grafting 
or transplantation [2]. Donor shortages, rapid progressions of diseases, expensive and 
inconvenient applications also limit conventional therapies [3]. For this reason, 
developing new technologies to replace or restore lost or damaged organs and tissues 
is a particular goal for modern regenerative medicine [4]. 
As an emerging science consisting of and applying mainly molecular biology and 
material engineering principles and methods, tissue engineering aims to develop 
biological substitutes for organs and tissues that have been damaged or lost their 
functions partially or completely [5, 6]. These biological substitutes must mimic 
histological organisation and function of organs and tissues they are established for 
[3]. To engineer new tissues, three major components are required: the right type of 
cells, a scaffold enabling attachment, proliferation and if needed differentiation of 
these cells, and signalling molecules such as growth factors for cell differentiation to 
desired cell lineage (Figure 1.1). Among these components, scaffolds play an 
important role in tissue engineering applications since they are involved in each and 
every step of new tissue formation [7, 8]. 
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Figure 1.1: An overview of tissue engineering approach [9]. 
1.3 Scaffolds 
Establishing a three-dimensional matrix for both in vitro and in vivo new tissue 
formation with desired structure and function is an important challenge in tissue 
engineering since it should be designed as an appropriate environment for supply of 
nutrients and removal of waste materials for seeded cells to survive [2]. 
Scaffolds, three-dimensional matrices fabricated from synthetic as well as natural 
polymers named biomaterials, have gained popularity and attraction due to structural, 
mechanical and biological properties they present for tissue engineering approaches 
[7, 10]. These scaffolds need to possess not only appropriate pore size, but also 
interconnected pores providing high surface area in order to provide a framework for 
cell adhesion, proliferation, differentiation and extracellular matrix formation highly 
similar to that of native tissue [7, 9-13]. Mechanical properties however should not 
deterioate with increasing porosity and should be able to sustain the tissue until the 
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new tissue formation. Some properties that are needed for a successful tissue 
engineering scaffold was given in Table 1.1. 
When compared with those from synthetic polymers, scaffolds produced using 
natural polymers are providing non-toxicity, good cell attachment and reasonable 
biocompatibility for avoiding unwanted host responses with minimal 
immunogenicity [14, 15]. Both chemical and architectural properties of scaffolds 
have a particular impact on new tissue formation: an excellent surface chemistry 
enables cell attachment, proliferation and differentiation whereas adequate 
mechanical properties maintain structure and functions of scaffolds after 
implantation and during new tissue formation at implant site [15, 16]. Therefore, 
fabrication methods such as freeze-drying, salt-leaching, electro-spinning are under 
development in order to prepare suitable constructs for regeneration of various tissue 
types such as skin, cartilage, bone, nerve, and liver [1, 16]. 
1.4 Scaffold Fabrication Techniques 
Several different methods have been developed and employed in order to 
manufacture scaffolds with desired structural, chemical and biological properties 
based on target tissue type using synthetic or natural materials [17]. Among these 
methods, freeze-drying, salt-leaching, gas foaming and electro-spinning are the ones 
that are widely used for tissue engineering applications. 
1.4.1 Freeze-Drying 
Freeze-drying, also called lyophilisation, is a two-step process of drying based on 
sublimation principle that removes frozen water from the sample prepared for 
scaffold fabrication [18, 19]. It is also one of the most studied scaffold preparation 
methods due to its simplicity and mild process conditions [13]. 
 
 
 
 
 
5 
 
Table 1.1: Basic characteristics of scaffolds for tissue engineering applications [9]. 
Properties Remarks 
Bioresorbable 
Foreign material and bulk degradation 
products should be eliminated from body 
by natural pathways 
Controlled porosity with interconnected 
pores 
Tailor-made cellular adhesion, growth, 
extracellular matrix secretion, 
angiogenesis, nutrition and oxygen 
transport without compromising 
mechanical strength 
Biodegradable 
Breakdown products of macromolecular 
degradation should not be toxic or 
immunogenic 
Controlled pore structure 
To provide greater diffusivity and higher 
diffusion coefficient for waste removal 
and nutrient transport 
High surface area-to-volume ratio 
For increased cell density, cell adhesion, 
proliferation, migration, and 
differentiation 
Mechanical stability 
Mechanical properties should match the 
replaced natural tissue to withstand in 
vivo stimuli 
Three-dimensional templating 
To assist cellular in-growth and provide a 
natural three-dimensional in vivo 
microenvironment 
Mimic natural ECM 
Properties and structures should be 
matched with natural ECM components 
to coordinate with biological cues 
Cellular compatibility 
Scaffold surfaces must show cellular 
compatibility and should not repel cells 
Vascular support 
To support angiogenesis and healthy 
regeneration 
Biocompatible 
Should not provoke any rejection, 
inflammation, immune response, etc. 
Surface modifiable 
Scaffold surfaces should allow chemical 
or biomolecularfunctionalisation to 
increase cell-material interactions 
Non-toxic Should not evoke toxicity to tissues 
Non-immunogenic 
Immunogenic response to tissue must not 
be evoked 
Non-corrosive 
Should not become corroded at 
physiological pH and body temperature 
Sterilisable 
Surfaces must be receptive to sterilization 
processes to avoid contamination 
Degradability rate matching with re-
growth rate 
For gradual transfer of load-bearing and 
support functions to newly growing 
tissues 
High water content 
Helps in generating hydrated in vivo 
environment 
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Sublimation, the main principle for freeze-drying, enables the frozen water to 
directly pass from solid state to vapour state, without passing through the liquid state, 
which takes place at pressure and temperature below 4.579 mm-Hg and 0.0099 
o
C, 
respectively. In order to freeze-dry a material, it needs to be frozen first and then 
subjected to a high vacuum enabling the frozen liquid (e.g. water) to sublime and 
leave only solid and dried components of the original solution. This process leads to 
highly porous polymer scaffold to be used in tissue engineering approaches [15, 19-
21]. 
Lyophilisation is performed at pressure and temperature conditions below the triple 
point so that the frozen liquid can sublime (Figure 1.2). Freeze-drying process starts 
from sample preparation and freezing to primary and secondary drying. The 
concentration gradient that emerges during the process between the drying front and 
condenser drives the removal of liquid in lyophilisation. Liquid crystals start to 
separate from the solution until it becomes maximally concentrated. The fundamental 
process steps for freeze-drying can be summarised as follows [19]: 
 Freezing: The material is frozen to provide a condition for low temperature 
drying. 
 Vacuum: After freezing, the material is placed under high vacuum to enable 
the frozen solvent in the solution to pass directly to vapour state 
(sublimation). 
 Heat: Heat is applied to accelerate sublimation. 
 Condensation: Condensation removes the solvent in vapour state by 
converting it back to a solid phase that enables the completion of 
lyophilisation process. 
Critical features including pore size and specific pore area for scaffolds produced by 
freeze-drying can be optimised by adjusting some processing parameters such as 
pressure/temperature and duration [21, 22].  Despite its broad range of benefits, this 
technique may be a time- and energy-consuming approach since it requires a long 
time period to completely eliminate solvents [19, 20]. 
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Figure 1.2: Phase diagram showing the triple point of water at 0.01 
o
C and 0.00603 
atm [23]. 
1.4.2 Solvent casting and particulate leaching 
Solvent-casting/particulate leaching method has been widely used to fabricate 
polymeric constructs with controlled porosity and surface-to-volume ratio [15, 20, 
24]. In this method, a water-soluble porogen, mostly salt, sugar, paraffin or gelatin 
spheres, is mixed in a polymer solution and then transferred into a mold with desired 
shape and volume. The solvent is then removed by evaporation or freeze-drying and 
the porogen is leached out using its solvent, generallydeionised water [9, 20]. 
Adjusting porogen dimension and porogen/polymer ratio enables to construct a 
scaffold with desired pore size and porosity, respectively. On the other hand, loss of 
biomolecules in the scaffold, weak removal of porogen particles or solvent and 
limitation in overall size of the scaffold can be addressed among disadvantages of 
particulate-leaching method [20]. 
1.4.3 Gas foaming 
The gas foaming method allows the fabrication of highly porous scaffolds in tissue 
engineering. To do this, a polymer solution is saturated with high pressure carbon 
dioxide (800 psi) forming phase separation of carbon dioxide molecules and pore 
nucleation (foaming) and thus eliminating organic solvent need as seen in particulate 
leaching method [9, 24]. These pores provide a significant increase in polymer 
volume and decrease in density of polymeric matrix. Three-dimensional biomimetic 
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construct isconsequently formed after completion of the process (Figure 1.3) [15]. 
However, lack of pore interconnectivity especially at the surface of newly 
established scaffolds makes them unsuitable for cells to be seeded [9]. 
 
Figure 1.3: General description for gas foaming method [20]. 
1.4.4 Electro-Spinning 
Electro-spinning method which requires high electric field was invented by Formhals 
in 1930s. This technique produces nanometrefibres and pores interconnected with 
each other that highly mimic natural extracellular matrix for cell adhesion and 
nutrient transportation [25-29]. When the applied electric field overcomes the surface 
tension, the polymer solution is ejected as jets toward collector systemand can be 
collected as fibres (Figure 1.4). The properties of these nanofibrescan be adjusted by 
changing process parameters such as viscosity and conductivity of polymer solution, 
voltage in the electric field, average molecular weight of polymer, distance between 
needles and collectors [26]. 
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Figure 1.4: General scheme for electro-spinning method [20]. 
1.5 Use of Synthetic sand Natural Polymers in Tissue Engineering 
In terms of tissue engineering and regenerative medicine applications, there are some 
important parametres to consider such as biocompatibility and reproducibility of 
manufacturing biomimetic materials that can be derived from nature or be 
synthesised in laboratory in the form of synthetic polymers, metals, alloys and 
ceramics [16, 30]. For this reason, increased demand for tissue engineering scaffolds 
has triggered an array of biomaterials in order to develop and improve methodologies 
that have been used [31]. 
Materials like polymers, metals and ceramics are widely used as cell scaffolds for 
tissue engineering. Synthetic and natural polymers have become the focus of many 
clinical trials, but each kind of polymer has its own limitations. Synthetic polymers 
can be easily processed and modified, whereas natural polymers provide better 
biocompatibility. On the other hand, different tissue types require specific physical, 
mechanical and degradation properties. As a result, it can be stated that there is no 
universal biomaterial that could meet all needs and properties of all tissues [32]. 
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1.5.1 Synthetic polymers 
The development of polymers for medical purposes has started with the need of 
biostable materials in order to use them during the lifetime of a patient. The first 
biodegradable polymer poly (glycolic acid) was used to fabricate the first, synthetic 
degradable suture line, ending the use of the ones made from animal intestines [33, 
34]. 
There is an increased demand and use of synthetic biomaterials for tissue engineering 
approaches. The advantage of using these kinds of materials is that they are more 
uniform and more predictable with respect to their both chemical and mechanical 
properties, making it possible to meet tissue-specific needs and other requirements 
such as being non-toxic and bioavailable since they are not derived from animal 
sources [35, 36]. Changing molecular weight, co-polymer ratio and monomeric 
substitutions enables polymer modification for desired degradation profile associated 
with native tissue properties. However, there are also biomaterials that cannot be 
degradable, and thus, can be used to replace large tissue defects that cannot induce 
their own regeneration [36]. 
1.5.1.1 Non-Biodegradable synthetic solymers 
Non-biodegradable synthetic polymers are mainly used in dental tissue engineering. 
However, problems due to infection and capsule formation around these biomaterials 
and the need for a second operation to remove them make their use disadvantageous 
for tissue engineering [36]. 
1.5.1.2 Biodegradable synthetic polymers 
Because of their physical properties, cost-effectiveness and low immune response in 
host tissues, synthetic polymers possess many advantages in order to be used to 
establish scaffolds for bone tissue regeneration [36]. 
Polyesters 
Polyesters, which are composed of ester linkage backbones and degraded by 
hydrolysis in vivo, are important biodegradable synthetic polymers. Important 
examples include poly (glycolide) (PGA), poly (lactide) (PLA), poly (caprolactone) 
(PCL), and poly (trimethylene carbonate) (PTMC). Due to their almost non-toxic 
degradation products, polyesters are extensively used to produce scaffolds. 
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Additionally, they are degraded by bulk erosion or surface erosion totally, resulting 
in controlled release of degradation products or other materials such as drugs for 
which they are used as delivery vehicles [36]. 
Poly (Ether-Ester) 
As a poly (ether-ester), poly (dioxanone) (PDS) is used in important biomedical 
applications since it possesses enhanced flexibility making it useful especially in 
esophageal dilation and vascular grafting. It is degraded by hydrolysis completely up 
to six months [36]. 
Poly (Ethylene Glycol) 
Poly (ethylene glycol) (PEG) composed of repeating ethylene oxide monomeric 
subunits is a highly utilised polymer with specific properties such as solubility in 
organic and hydrophilic solvents. PEG is used to create less hydrophobic polymers, 
making cell adhesion and proliferation on scaffolds possible [36]. 
1.5.2 Natural polymers 
Proteins and polysaccharides as natural polymers are being widely used and, based 
on their diverse chemical and physical properties, they play an important role in 
tissue engineering applications [35]. 
1.5.2.1 Proteins 
Materials made from proteins are useful in biomedical applications since they are the 
major components of natural tissues and display a well-controlled natural 
degradation profile (Table 1.2) [35]. 
Collagen 
Collagen is an ECM protein, which is abundantly found in musculoskeletal tissues. 
There are approximately 22 different types of collagen proteins, and they can be 
extracted from animals such as rats, bovines and humans. By making use of collagen 
in different concentrations, features of a scaffold can be adjusted accordingly. Some 
studies already demonstrated collagen possesses similar physical and mechanical 
properties to those of natural tissues and provides a better cell adhesion and growth 
in vitro. Collagen scaffolds can be designed as tubes, sponges, powders and sheets, 
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and are used in muscle, cardiovascular, skin, cartilage, tendon and ligament tissue 
engineering approaches (Figure 1.5) [35]. 
 
Figure 1.5: Examples for some commercially available collagen scaffolds [35]. 
Gelatin 
Gelatin is a hydrolysed protein form of collagen obtained by denaturing its triple-
helix structure into single-stranded molecules [37-40]. For gelatin extraction, 
collagen molecules are obtained from bovine or porcine skin or bone as a by-product 
of meat-processing industry. Extracts from collagen are derived under either acidic 
or basic conditions, and referred to as type A or type B gelatin, respectively [41]. 
Gelatin is an interesting and important polymer for tissue engineering applications. It 
promotes cell attachment, proliferation and differentiation, and due to its 
biodegradability, biocompatibility and low cost, is used in many applications in the 
pharmaceutical, medical and food industries [35, 39, 42]. 
Gelatinhas been used generally in combination with other materials in order to form 
scaffolds since it possesses low mechanical properties on its own [37]. To use gelatin 
as a biomaterial, its instability issue can be overcome by covalent cross-linking 
methods either without prior modification or after functionalisation of its side groups 
[41].   
Gelatin has both acidic and basic functional groups that enable its chemical 
modification with other polymers [37]. Importantly, even after hydrolysis from 
collagen, gelatin retains its bioactive sequences (e.g. the arginine-glycine-aspartic 
acid (RGD) peptide) for cell attachment in its backbone [41]. 
Elastin 
Elastin is an extracellular matrix protein and found abundantly in tissue where 
elasticity is of great importance. The ratio of elastin in blood vessels, elastic 
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ligaments, lungs and skin is 50%, 70%, 30% and 2-4% of their dry weights, 
respectively. Associated with a wide range of elastic peptide and protein sequences 
existing in different lengths and compositions, elastin is not a single, well-defined, 
but a rich molecule in glycine, proline and lysine [33]. 
Because of causing calcium-rich precipitates when used in heartvalve prosthetic 
devices and preventing cells attachment and growth on its surface, elastin serves as 
an important example showing that using natural polymers is not a guarantee for 
clinically successful tissue engineering applications [33]. 
Keratin 
Keratin, a fibrous protein found abundantly in nature, is the main constituent of hair, 
wool, nail, horn and hooves of mammals, birds and reptiles [43-44]. It contains 
cysteine amino acid residues (7-20%), the oxidation of which leads to intermolecular 
and intramolecular covalent bonds responsible for the tough keratin fibres [43].  
Its cell adhesion sequences RGD, arginine-glycine-aspartic acid, and LVD, leucine-
asparagine-valine found in natural extracellular matrix proteins and cellular binding 
motifs that mimic cellular attachment sites make keratin proteins useful for the 
development of various tissue engineering scaffolds [43]. Like many other natural 
biomaterials, it possesses unique biological activities and biocompatibility [44]. 
Silk 
Silk fibres have been widely used in people’s daily life as a product from textile 
industry and also as an FDA-approved biomaterial for biomedical purposes such as 
human-made blood vessels, surgical sutures and repair materials due to its high 
oxygen permeability, biocompatibility, controllable biodegradability and excellent 
mechanical properties [45-50]. In tissue engineering applications, scaffolds produced 
from silks by salt-leaching, freeze-drying, gas foaming or electro-spinning 
techniques provide supporting constructs for cells including fibroblasts, osteoblasts, 
hepatocytes and stem cells [45]. 
Silk protein secreted by Bombyxmorisilk worm consists of fibroin and sericin [51]. 
The silk fibroin is present within silk worm cocoons as a double-stranded fibre, 
which is coated with glue-like protein, called sericin. The raw silk fibre mass is 
composed of about 20-30% sericin and 70-80% fibroin with a very low amount of 
waxes and carbohydrates. Pure silk fibroin protein is prepared by a degumming 
14 
 
procedure and thus separated from the sericin protein since sericin may cause 
inflammatory responses [52-54]. 
Silk fibroin consists of a heavy protein chain with approximately 390 kDa molecular 
weight and a light protein chain with approximately 26 kDa molecular weight 
connected by a disulfide bond. The heavy chain of silk fibroin is composed of a 
block co-polymer arrangement of primarily hydrophobic amino acids and is the 
source for robust mechanical properties, whereas the light chain consists of about 
47% hydrophobic amino acid residues and is crucial for proper cellular secretion of 
the heavy chain (Figure 1.6). The amino acid sequence of silk fibroin heavy chain 
mainly consists of Gly-X repeats where X refers to alanine, serine or tyrosine [52, 
55-57]. 
Silk fibroin can exist in three different structural morphologies as silk I, silk II and 
silk III. Silk I form is water-soluble, whereas silk II is an insoluble form consisting of 
extended anti-parallel β-sheets stabilised by hydrogen bonding. The silk III is helical 
and observed at the air-water interface [52, 55, 58]. 
Sericin proteins have a molecular weight ranging from 20 to 400 kDa depending on 
gene coding and post-translational modifications. The primary amino acid sequence 
of most sericins contains a repeat of 38 amino acids composed of serine, glycine, 
asparagine, aspartic acid, and a random coil secondary structure [52]. 
 
Figure 1.6: The hydrophobic β-sheet structure of silk fibroin embedded in the 
amorphous regions, which are hydrophilic and hold moisture (water  molecules are  
shown by blue dots) [55]. 
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Proteoglycans 
Proteoglycans, PGs, consisting of one or more glycosaminoglycan (GAG) chains 
attached to serine residues within a core protein are major components of 
extracellular matrix. They show great structural diversity since a PG may contain 
various GAG chains in type, number and length with a different core protein than 
other PGs. The core protein and GAG chains of a proteoglycan play significant roles 
in tissue remodelling, intracellular signalling, protein uptake, cell migration and other 
critical functions of natural tissues. Therefore, these proteins are in specific interest 
to many researchers for tissue regeneration techniques and can be introduced onto 
the surface of biomimetic constructs, used alone or in combination with other matrix 
proteins such as fibrin, collagen to create more bioavailable materials with 
appropriate biological and physical properties [33]. 
Table 1.2: Biodegradable natural polymers and their properties [34]. 
Type of 
protein 
Source of protein Function of protein 
Collagen 
Isolated from 
cattle, fish, and 
other species 
Key component of tissue architecture, provides 
mechanical strength, supports cell attachment 
and growth, and provides a biocompatible 
matrix for cell transplantation. Used 
extensively as a tissue expander and bulking 
agent in cosmetic products. 
Gelatin 
Partially 
hydrolized 
collagen 
Used in food industry, widely explored by 
researchers as a matrix for three-dimensional 
cell culture and as a component of tissue-
engineering scaffolds. 
Elastin 
Isolated from 
elastic tissues of 
cattle and birds 
Key component of tissue architecture, provides 
elasticity to tissues. 
Keratin 
Isolated from 
skin, hair and 
nails of cattle and 
birds 
Key structural component of outer skin, hair 
and nails.Used as a matrix for cell growth and 
as a component in wound dressings and skin 
care products. 
Silk 
Isolated from 
insect larvae 
Used in the textile industry because of its 
extraordinary strength. Also studied as a 
component of tissue engineering scaffolds and 
as a cell culture substrate. 
Proteoglycans 
Various tissue 
extracts 
Used in research of cell-matrix interactions, 
matrix-matrix interactions, cell proliferation, 
cell migration. 
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1.5.2.2 Polysaccharides 
Polysaccharides are long carbohydrate molecules that contain repeated 
monosaccharide units bound with each other by glycosidic bonds, and form the 
second largest biopolymer class of extracellular matrix, where some 
glycosaminoglycans like hyaluronic acid (HA) and chondroitin sulphate (CS) 
comprising repeating disaccharide units are present (Table 1.3) [59]. Hyaluronic acid 
is the most prominent glycosaminoglycan with responsibility for in vivo regulation of 
the water content of natural tissues and contributing to the viscoelastic behaviour of 
cartilage tissue. It can also promote angiogenesis [59]. 
Cellulose 
Mainly found in cell walls of plants, cellulose is a tough, water-insoluble, fibrous 
material composed of D-glucose units linked together by glycosidic bonds. Despite 
its some disadvantages as a biomaterial such as being non-biodegradable in humans 
because of lack of specific digestive enzymes, cellulose is being commercially used 
in paper, wood and textile industries. Apart from the molecule itself, some cellulose 
derivatives such as methylcellulose, hydroxyl propyl cellulose and 
carboxymethylcellulose are used as drug delivery agents, barrier for preventing 
surgical adhesion or even fabricating scaffolds for cartilage tissue engineering [33]. 
Starch 
Starch is also composed of D-glucose units bound together by different glycosidic 
bonds than in cellulose, making it digestible and thus useful as an important human 
nutrient. Linear and branched chains named amylose and amylopectin, respectively, 
are found in starch and their proportion in the molecule dictates whether it can be 
totally water-insoluble or partially soluble at room temperature [33]. 
Starch is not an obvious option for tissue engineering applications since it is not 
biodegradable in human tissues even though it can be digested in the gut. However, 
some polymers consisting of starch molecules can display biodegradable and 
biocompatible properties, and therefore can be used in cartilage tissue regeneration 
approaches and as drug delivery agents [33]. 
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Alginate 
Alginates are anionic polysaccharides and binary copolymers of L-guluronic acid (G 
monomer) and D-mannuronic acid (M monomer). The ratio of these two monomers 
in alginate polymers depends on the type and growing season of the source seaweeds 
that may have a negative impact for the production of materials with same or 
comparable properties. The proportion and distribution together can also affect the 
physiochemical properties of the polymer since cells to be attached onto the scaffolds 
made from alginate molecules will be sensitive to local and natural differences of the 
biomaterial. Like other natural polymers, the purity of alginate needs to be evaluated 
to prevent contamination caused by endotoxins, heavy metals and other impurities 
[60]. 
Glycosaaminoglycans 
Glycosaminoglycans (GAGs) consisting of repeating disaccharide units usually 
include auronic acid component such as glucuronic acid and a hexosamine 
component such as N-acetyl-D-glucosamine. Chondroitin sulphate, dermatan 
sulphate, keratansulphate and heparansulphate are the predominant GAG types 
attached to proteoglycan core proteins by specific carbohydrate sequences containing 
three or four monosaccharides [33].  
Hyaluronic acid (HA), the largest GAG molecule, can be easily chemically modified 
in order to yield an appropriate biomaterial for various biomedical applications. It is 
not an antigenic material and does not provoke an immune response. In addition, 
hyaluronic acid is a desirable material in medical device developments and has been 
used as a viscoelastic in eye surgery since 1976 since it can be easily isolated and 
modified. The benzyl ester of HA is also being studied for use in vascular grafts [33]. 
Chitin/Chitosan 
Chitosan is a natural, cationic, non-antigenic, biocompatible and biodegradable 
amino-containing polymer that is derived from chitin through a partial deacetylation 
process that has a similar structure to the naturally present glycosaminoglycans in 
extracellular matrix, and consists of D-glucosamine and N-acetyl-D-glucosamine 
units [61-66]. Because of its cationic nature, chitosan is also bioadhesive, 
haemostatic and antimicrobial, and bind and prolong the activity of growth factors 
that promote cell-cell and cell-matrix interactions [66]. The chemical and mechanical 
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structure of chitosan can be easily modified to generate materials with novel 
properties and functions [67]. For this reason, it is widely used for drug delivery, 
wound dressing and tissue engineering applications [66]. On the other hand, similar 
to gelatin, it possesses low mechanical strength and a high biodegradation rate [62]. 
Table 1.3: Biodegradable and widely used natural polysaccharides and their 
properties [34]. 
Type of 
polysaccharide 
Source of 
polysaccharide 
Function of polysaccharide 
Cellulose 
Cell wall of green 
plants 
Main structural component of 
plants which keeps the stems, 
stalks and trunks rigid 
Type of 
polysaccharide 
Source of 
polysaccharide 
Function of polysaccharide 
Starch (Amylose and 
Amylopectin) 
Present in all staple 
foods 
Important in plant energy storage 
Alginate 
Found in the cell 
walls of bacteria 
Protects bacteria from 
engulfment by predatory 
protozoa or white blood cells 
(phagocytes) 
Glycosaaminoglycans Widely distributed 
Cell-matrix interactions, matrix-
matrix interactions, cell 
proliferation, cell migration 
Chitin/Chitosan 
Major component of 
the exoskeleton of 
insects, shells of 
crustaceans, cell walls 
of fungi 
Structural component 
1.6 Non-polymeric Materials 
1.6.1 Ceramics 
Apart from the polymers, most prominent materials used in bone tissue engineering 
applications are ceramics because of their mechanical and structural advantages. 
Many of them, such as hydroxyapatite-based ceramics, are not biodegradable, but do 
still have an advantegous position in large bone defects’ replacement. Some ceramics 
like tri-calcium phosphate and calcium carbonate can be degraded in vivo, but 
preferred for repairing small defects in bone tissues [36]. 
1.6.2 Bioactive glass 
Bioactive glass is generally used in combination with ceramic materials due to its 
ability to promote in vivo tissue adhesion. It can initiate hydroxyl carbonate apatite 
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coating on its surface that is similar to hydroxyapatite particles in bone tissues. The 
interaction between these minerals allows the scaffold to adhere to the bone. In 
addition, bioactive glass can also be used as delivery molecules for therapeutically 
relevant drugs to reach the site of regeneration [36].  
1.7 Bone Tissue Regeneration 
1.7.1 Bone tissue structure 
Natural bone consisting of both inorganic minerals and biomacromolecules is a 
highly functionalised connective tissue that forms the skeletal framework of human 
body due to its cellular and structural organisation and component material properties 
directing its own formation (Figure 1.7) [64, 68, 69]. The biomacromolecules of 
bone tissue are mainly collagen fibrils that provide strength and resistance, and the 
inorganic minerals are mainly hydroxyapatite (HA) molecules that resist 
compression and crystallisealong the collagen fibril axis [64, 70]. 
The organic part of bone tissue makes its 35%, whereas the rest is made of inorganic 
matrix consisting of hydroxyapatite as well as carbonate and inorganic salts. The 
organic extracellular matrix of natural bone tissue is composed of complex and self-
assembled molecules such as collagen, which makes up approximately 90-95% of 
the organic ECM, and osteopontin, osteonectin, osteocalcin, bone sialoprotein, 
hyaluronan and proteoglycans [71].  
The overall bone structure is divided into two different subgroups: the cortical bone, 
which is more compact, and the cancellous bone appearing like a sponge and 
possessing pore filled with bone marrow or fat [71]. Bone tissue is continuously 
renewed and remodelled by formation and resorption of bone-forming osteoblasts 
and bone-resorbing osteoclasts to adopt to mechanical loads, hormones, cytokines 
and other external physical parameters [69, 71]. 
20 
 
 
Figure 1.7: The structure of natural bone tissue showing structural and cellular 
components [69]. 
The osteocytes comprising more than 90% of all bone tissue cells in adult animals 
are believed to be the main cellular responsible unit for the transduction of 
physiological and mechanical mediators for differential cellular and tissue responses 
by cell-cell or cell-ECM interactions [68, 71].  
Osteoclast cells, derived from hematopoietic stem cells, dissolve hydroxyapatite 
molecules by releasing hydrochloric acid and a protease mixture degrading the 
organic bone matrix in collagen fibres. They are involved in removing cracks and 
can also serve as immune cells by secreting cytokines that are able to affect the cells 
in the environment [71]. 
Another type of bone tissue cells, osteoblasts, is derived from mesenchymal stem 
cells that are located in the bone marrow serving as a valuable cell source for tissue 
generation through differentiation towards osteogenic lineage. After they are 
encapsulated within their own matrix, they gain a different morphology and become 
osteocytes [71]. 
1.7.2 Bone tissue regeneration approaches 
Bone fractures have the ability to heal by themselves within a couple of weeks. Large 
or critical bone defects that occur because of tumour, birth defects, accidents, aging, 
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infection or other physiological reasons may need major important surgical 
interventions since they heal relatively slowly or not at all [59, 68, 69]. Such critical 
defects of bone tissue are treated by transplantation of autogenic (patient’s own 
tissues) or allogenic (tissues from other patient(s)) cancellous bone grafts or by 
application of growth factors such as bone morphogenic protein, BMP-2, or a 
combination of these methods [59]. According to a report published in the US, each 
year 1.3 million people undergo a bone graft surgery [72]. 
Possible second site damages, additional pain, longer healing time for the defected 
site, limited supplyanddonor availability, disease transmission and infection risk need 
to be taken into consideration as existing disadvantages of autograft or allograft 
tissue transplantation [70, 72]. These limitations can be circumvented by application 
of a scaffold structure with desired shape and size in order to treat and/or replace 
damaged or diseased bone tissues. These scaffolds can be cell-free or pre-seeded 
with cells either from patient’s own tissues or from bone tissues of a donor. In any 
case of these two approaches, the cells can differentiate and proliferate within the 
entire scaffold structure and take over the functions of target tissue with time [72]. 
1.7.3 Bone tissue engineering 
Bone tissue engineering is a promising alternative to currently available treatments in 
order to regenerate bone tissue defects as it encompasses bone biology and 
engineering principles by making use of biomimetic scaffolds [69, 71]. Various 
biocompatible polymers, natural or synthetic polymers, have been studied for tissue 
engineering applications to produce scaffolds for bone tissue regeneration [64]. 
An ideal scaffold must have some important properties such as biocompatibility, 
osteoconductivity, good mechanical integrity, bioactivity, a degradation rate 
matching with the formation rate of new tissue at the site of damage and 
interconnected porous structure [70]. Natural polymers such as chitosan, collagen, 
cellulose, gelatin and silk fibroin are preferred over synthetic polymers since the 
natural polymers possess better biodegradability, non-toxicity, biosecurity and 
biocompatibility [64]. Among natural polymers, silk fibroin has been shown to be a 
promising biomaterial due to biological and mechanical features it provides [71].   
In a study published in 2014, Orlova et. al. studied porous silk fibroin and silk 
fibroin/ gelatincomposite sceffolds produced by freeze-drying method and tried to 
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find out how the gelatin content in composite scaffold affects the scaffold properties. 
For this reason, they produced various silk fibroin scaffolds with 10, 20, 30, 40 and 
50% gelatin content, and examined scaffold integrity, elasticity, cell proliferation, 
adhesion and migration. According to their findings, the samples with 40% and 50% 
gelatin content lost their structural integrity after aweek of incubation in water. All 
samples were elastically deformedby direct mechanical pressure, and increasing 
gelatin ratio resulted in increased lost in scaffold elasticity. On the other hand, 
addition of gelatin to the scaffold increased cell adhesion and accelarated cell 
proliferation [4]. 
In another study published by Damrongsakkul et. al. in 2013, the researchers 
modified human cancellous bone with silk fibroin/gelatin blend. For this purpose, 
they studied silk fibroin-gelatin solutions at a weight ratio of 50/50 with solution 
concentrations 1, 2 and 4 w/v%. Based on their results, all bone scaffolds modified 
with the blend showed smaller pore size, less porosity and lower compressive 
modulus when compared with unmodified human cancellous bone structure. The 
scaffolds modified with 2 and 4 w/v % solution concentrations stimulated cell 
attachment, proliferation and osteogenic differentiation of mesenchymal stem cells 
derived from bone marrow in comparison to the original cancellous bone [14]. 
Kaplan et. al. designed a green process, avoiding the use of organic solvents and 
chemical processes, to produce silk fibroin-based scaffolds for tissue engineering 
applications. According to their results published in 2010, addition of gelatin to the 
silk fibroin solution changed the conformation of silk fibroin and its interaction with 
water. They also showed that the pore sizes of silk fibroin-based scaffolds can be 
controlled by adjusting polymer ratios in blend solutions, and silk fibroin-gelatin 
scaffolds improved fibroblast cell interaction in in vitro cell culture tests [45].    
23 
 
2.  MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Chemicals 
The list of chemicals that were used in this study and their suppliers were given in 
Appendix A. The gelatin was also listed in Appendix A.  
2.1.2 Solutions 
The solutions that were used in this study and their compositions were given in 
Appendix B and Appendix C. 
2.1.3 Laboratory equipment 
The laboratory equipment that were used in this study was listed in Appendix D. 
2.2 Methods 
2.2.1 Fibroin extraction from Bombyx mori silkworm cocoons 
The silk fibroin used in this study was extracted according to a process from 
Rockwood et. al. [74]. The process consisted of following steps: 
1. A 2 litres glass beaker filled with 2 litres of ultrapure water was prepared, 
covered with aluminium foil and then heated until boiling. 
2. Meanwhile, silkworm cocoons were cut into smaller pieces of 5 g weight.  
3. Sodium carbonate (4.24 g) was added to the water and completely dissolved. 
4. The cocoon pieces were added to the boiled water and cooked for 30 minutes. 
It was occasionally stirred with a spatula to promote good dispersion of 
fibroin. 
5. The silk fibroin was removed and then cooled in ultrapure water. The excess 
water was squeezed out of the silk, and the sodium carbonate solution in the 
silk was discarded. 
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6. The fibroin was put into a 1 litre beaker filled with 1 litre of ultrapure water 
and a stir bar.  
7. The fibroin was rinsed in water changed for every hour while gently stirring 
on a stir plate. 
8. The steps 6 and 7 were repeated for a total of three times. 
9. After the third wash, the silk was removed, squeezed well, and then spread 
out on a clean aluminium foil. 
10. The amount of 9.3 M lithium bromide needed to make a 20 w/v % solution 
based on the amount of dried silk fibroin was calculated and prepared 
according to Equation 2.1. Since silk to LiBr should be 1 to 4, the amount of 
the dried silk fibroin was multiplied by 4 to get the total volume of 9.3 LiBr 
needed. 
 (86.85 
g
mol
) (9.3 
mol
L
)(
1L
1000 mL
) (X)= g of LiBr (2.1) 
11. The silk fibroin was packed tightly into a 50 mL glass beaker, and the 
required amount of LiBr solution was added on top. 
12. The fibroin was dissolved in an oven at 60 oC for overnight.  
13. The dialysis cassettes were hydrated in water for a few minutes. 
14. 12 mL of the silk fibroin-LiBr solution was inserted into a 3-12 mL dialysis 
cassette with the help of a 20 mL syringe. 
15. Dialysis against 1 litre of ultrapure water per 12 mL cassette was performed. 
To ensure mixing, a large stir bar was used. The water was changed every 
three hours for three times a day for 2 days (6 changes within 48 hours). 
16. The silk fibroin was removed from the dialysis cassettes with another syringe, 
splitted into three 15 mL conical tubes. A tube filled with water was used for 
counterbalance. 
17. Centrifugation was performed at 9,000 rpm at 4 oC for 20 minutes to remove 
impurities.  
18. The tubes were removed from the centrifuge carefully. The silk was 
transferred into another tube. 
19. The steps 17 and 18 were repeated. 
20. In order to determine the silk fibroin concentration, 1 mL of the silk fibroin 
solution was weighed and dried in an oven at 60 
o
C overnight. The dried silk 
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fibroin was weighed and the yield of the solution in percentage was 
calculated according to Equation 2.2.  
(The dried weight of silk fibroin - the wet weight of silk fibroin)
The wet weight of silk fibroin
x100 (2.2) 
2.2.2 Preparation of silk fibroin-gelatin blend solutions 
Silk fibroin was extracted from Bombyx mori silkworm cocoons according to a 
process that had been adopted from Rockwood et. al (Section 2.2.1) [74]. The gelatin 
from bovine skin Type B was commercially purchased (Appendix A). 
A stock gelatin solution with 4% (w/v) concentration was prepared by dissolving 
powdered gelatin in ultrapure water with the help of a magnetic stirrer at 60 
o
C for 
approximately half an hour. As a cross-linking agent for gelatin polymer, 
glutaraldehyde solution with 1% (w/v) concentration was added into the stock gelatin 
solution at a ratio of 1:32 (v/v), as adopted from Yang et. al. and mixed with the help 
of a magnetic stirrer at 60 
o
C for 15 minutes (Appendix A) [3]. The stock gelatin 
solution was then splitted into different beakers and diluted to 1% (w/v), 2% (w/v) 
and 3% (w/v) in order to prepare silk fibroin-gelatin blend solutions. 
After the extraction process, a stock silk fibroin solution of 5.8% (w/v) was yielded. 
The stock solution was then transferred into different beakers and diluted to 3% 
(w/v), 2% (w/v) and 1% (w/v) in order to prepare silk fibroin-gelatin blend solutions. 
Once the stock solutions were prepared and then diluted to desired concentrations, 
the corresponding silk fibroin and gelatin solutions were mixed at a ratio of 1:1 (v/v). 
To do so, the diluted silk fibroin solutions were added into the gelatin solutions with 
appropriate concntrations and were gently mixed with the help of a magnetic stirrer 
at approximately 40 
o
C for half an hour. Totally, five different blend solutions were 
prepared with total polymer concentration of 4% (w/v). The compositions of these 
solutions were described in Table 2.1. The solution were named after the weight to 
volume ratios of each component in the blend. The “F” and “G” represented silk 
fibroin and gelatin, respectively.  
The blend solutions were cooled at 4 
o
C for 24 hours and then frozen at -20 
o
C until 
lyophilisation, as adopted from Yang et. al. [3].   
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Table 2.1: Compositions of silk fibroin-gelatin blend solutions. 
 
Silk Fibroin Content 
(% w/v) 
Gelatin Content 
(% w/v) 
Total Polymer Content 
(% w/v) 
F4-G0 4 0 4 
F3-G1 3 1 4 
F2-G2 2 2 4 
F1-G3 1 3 4 
F0-G4 0 4 4 
2.2.3 Lyophilisation of silk fibroin-gelatin blend solutions 
The frozen silk fibroin-gelation solutions were lyophilised with the help of a freeze-
dryer (Appendix D). The freeze-drying parametres were -55 
o
C and 24 hours for 
main drying step and -30 
o
C and 1 hour for final drying step. Following 
lyophilisation process, the freeze-dried samples were treated with an aqueous 
solution of 99% methanol for half an hour and dried in a vacuum hood for an 
additional half an hour, as adopted from Chomchalao et. al. [11] (Appendix A). The 
amount of methanol was calculated based on the weight of silk fibroin polymer in the 
blend solution. For 1.7 g of silk fibroin, 1 mL of 99% methanol was used [74]. The 
methanol treatment enabled water-insoluble silk fibroin polymer through β-sheet 
formation. The samples were then kept in a desiccator. 
2.2.4 Characterisation of silk fibroin-gelatin composite scaffolds 
2.2.4.1 Analysis with scanning electron microscopy 
The porosity and surface morphology of composite scaffolds were examined by 
Scanning Electron Microscope (Appendix D). The surfaces of samples were scanned 
at approximately 100x magnification. 
2.2.4.2 Analysis with fourier transform infrared spectroscopy 
Fourier transform infrared (FTIR) spectra of freeze-dried composite scaffolds were 
taken in order to examine the secondary structures of the silk fibroin-gelatin sponges 
(Appendix D). 
2.2.5 Water-uptake test of silk fibroin-gelatin composite scaffolds 
The water-uptake test for F3-G1, F2-G2 and F1-G3 composite scaffolds was 
performed based on a process that had been adopted from Lerdchai et. al. [75]. First, 
dry samples were weighed (Wd) and then immersed in phosphate buffered saline 
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solution (0.01 M, pH 7.4) at 37 
o
C for 24 hours (Appendix B). After that, the 
excessive water was removed from the sample surfaces and the swollen samples 
were weighed (Ws). The percentage of water absorbed by samples was calculated 
according to the Equation 2.3. The test was repeated for three samples of each 
composite scaffolds and their average percentage was calculated. 
Water-uptake ratio (%) = 
Ws-Wd
Wd
x100       (2.3) 
2.2.6 3-day biodegradation test of silk fibroin-gelatin composite scaffolds 
A three-day in vitro biodegradation test for F3-G1, F2-G2 and F1-G3 composite 
scaffolds was performed to determine an optimum enzyme concentration for the 
main biodegradation assay that lasted 28 days. 
Three enzyme solutions with different concentrations were prepared from powdered 
Protease XIV (from Streptomyces griseus with 3.5 units/mg, Appendix A). First, a 
stock enzyme solution with 1 U/mL concentration was prepared according to the 
Equation 2.4. The amount of powdered Protease XIV enzyme was dependent on the 
volume of stock enzyme solution. For instance, for an enzyme solution with 15 mL 
volume and 1U/mL concentration, 4.29 mg of enzyme powder was dissolved in PBS 
(pH 7.4) at room temperature.  
Enzyme concentration (U/mL) = 
3.5 units
mg
x
mg
mL
        (2.4) 
The stock enzyme solution was stored at -20 
o
C. The stock solution was transferred 
into different conical centrifuge tubes and diluted with PBS (pH 7.4) to prepare 
enzyme solutions with 0.05, 0.1 and 0.2 U/mL concentrations. As adopted from a 
study of Lerdchai et. al., sodium azide was added to the enzyme solution at a ratio of 
0.01% at room temperature (w/v) in order to prevent microbial growth around the 
samples (Appendix A) [75]. The dry weight (Wi) of F3-G1, F2-G2 and F1-G3 
composite scaffolds were calculated. Then, the samples were immersed separately in 
each enzyme solution and incubated at 37 
o
C for three days. After that, the samples 
were freeze-dried and weighed (Wf). Freeze-drying parametres were -55 
o
C and 24 
hours for main drying step and -30 
o
C and 1 hour for final drying step. The remaining 
weight ratio of samples were calculated based on Equation 2.5. The test was repeated 
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for three samples of each composite scaffold and their average was calculated. The 
control samples were immersed in PBS solution (pH 7.4)  that contained no protease 
enzyme and sodium azide. 
Remaining weight ratio (%) = 
Wf
Wi
 x 100        (2.5) 
2.2.7 Biodegradation test of silk fibroin-gelatin composite scaffolds 
The main in vitro biodegradation test that lasted 28 days was conducted by using a 
Protease Type XIV enzyme solution of 0.05 U/mL for F3-G1 and F2-G2 composite 
scaffolds. The enzyme solution was prepared as previously described in Section 2.2.5 
[75]. The control samples were immersed in PBS solution (pH 7.4)  that contained no 
protease enzyme and sodium azide.  
The test was adopted from Teimouri et. al. [5] and Lerdchai et. al. [75]. First, the 
samples were weighed (Wi) and then placed into 12-well plates in which they were 
immersed in Protease XIV enzyme solution and incubated at 37 
o
C for different time 
intervals of 7, 14, 21 and 28 days. The enzyme solution was replaced with fresh 
enzyme solution that had been prepared from the stock enzyme solution every 2 days 
to enable continuous enzymatic activity. After each time period, the corresponding 
samples were taken out, the excessive enzyme solution was removed and the samples 
were freeze-dried. The freeze-drying parametres were -55 
o
C and 24 hours for main 
drying step and -30 
o
C and 1 hour for final drying step. After that, the freeze-dried 
samples were weighed (Wf) and the percentage of remaining sample weight was 
calculated according to the Equation 2.3.  
The samples were visualised after biodegradation study by scanning electron 
microscope at approximately 60x magnification.   
2.2.8 Biomineralisation  test of silk fibroin-gelatin composite scaffolds 
The in vitro biomineralisation  test was conducted for F3-G1 and F2-G2 composite 
scaffolds, as adopted from Teimouri et. al. [5]. The samples were placed into 12-well 
plates, immersed either in 1x modified simulated body fluid or in 3x modified 
simulated body fluid solutions and then incubated at 37 
o
C for different time intervals 
of 1 day, 4 days and 7 days. The modified simulated body fluid (mSBF) solutions 
were prepared as described in Appendix C [73]. For samples that were incubated for 
29 
 
7 days, the mSBF solution was replaced with fresh solution at the end of the 4
th
 day 
of the test. After each time period, the corresponding samples were taken out, rinsed 
two times with ultrapure water to remove adsorbed minerals and freeze-dried. The 
freeze-drying parametres were -55 
o
C and 24 hours for main drying step and -30 
o
C 
and 1 hour for final drying step. After that, the samples were examined by scanning 
electron microscopy and fourier transform infrared spectroscopy to determine 
whether hydroxyapatite crystals were formed on scaffold surface.    
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3.  RESULTS AND DISCUSSION 
3.1 Characterisation of Scaffolds 
3.1.1 Morphology of scaffolds 
The presence and overall distribution of pores on scaffolds’ surfaces were 
determined by scanning electron microscope images that were given in Figure 3.1. 
When all silk fibroin-gelatin  composite scaffolds were examined, it could be seen 
that F2-G2 (Figure 3.1b) and F1-G3 (Figure 3.1c) samples showed better and 
uniform surface porosity and homogenous pore distribution. For scaffolds consisting 
of only one polymer, the one constructed with gelatin, F0-G4 (Figure 3.1e) seemed 
to have a relatively porous surface structure when compared to the one prepared from 
only silk fibroin (Figure 3.1a). The F4-G0 samples formed distinct layers instead of 
porous structures. The SEM images of F4-G0, F3-G1, F2-G2, F1-G3 and F0-G4 
samples showed that increasing the gelatin content in silk fibroin-gelatin blend 
solutions led to decreased layer formation and more porous scaffold structures. Pore 
formation was more apparent for samples that contained the gelatin polymer above 
50% of total polymer blend. 
The SEM images and porosity analysis results obtained in this study were consistent 
with the results previously reported by some researchers. Lu et. al. showed that 
addition of gelatin to aqeuous silk fibroin solution changed the silk fibroin 
conformation and silk fibroin-water interactions by affecting hydrophilic interactions 
between silk fibroin, gelatin and water and prevented formation of separate layers. 
According to their results, the gelatin content above 20% of total silk fibroin-gelatin 
blend provided more and more porous scaffolds [45]. 
In another study published by He et. al. in 2012, the researchers showed that 
increasing gelatin content in silk fibroin-gelatin blends gradually changed the 
morphology of silk fibroin-gelatin scaffolds from lamellar to porous structure [49]. 
In a recent study, Lerdchai et. al. observed a homogenous porous structure and 
interconnected pores when they examined the morphology of silk fibroin-gelatin 
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scaffolds. They also showed that the porosity of silk fibroin-gelatin composite 
scaffolds increased as the gelatin content in the scaffolds was increasing [75].  
The morphologies obtained in this study were in consistency with the results of other 
studies that were previously reported. It can be concluded that increasing gelatin 
content in silk fibroin-gelatin composite scaffolds reduced separate layer formation 
and formed more and more homogenous porous scaffold structure. 
Based on these results, F3-G1, F2-G2 and F1-G3 samples were selected for water-
uptake and 3-day in vitro biodegradation tests because of their homogeneous porous 
structures and overall morphologies. 
 
Figure 3.1: SEM images of F4-G0 (a), F3-G1 (b), F2-G2 (c), F1-G3 (d) and F0-G4 
(e) samples. 
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Figure 3.1 (continued): SEM images of F4-G0 (a), F3-G1 (b), F2-G2 (c), F1-G3 (d) 
and F0-G4 (e) samples. 
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Figure 3.1 (continued): SEM images of F4-G0 (a), F3-G1 (b), F2-G2 (c), F1-G3 (d) 
and F0-G4 (e) samples. 
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3.1.2 Effect of methanol treatment on chemical structures of scaffolds 
Methanol was reported to produce highly-stable beta-sheet protein secondary 
structure [76]. Thus, the effect of methanol treatment on the secondary structure of 
silk fibroin was investigated by comparing FTIR spectra of F3-G1, F2-G2 and F1-G3 
samples with and without methanol treatment.  
The secondary structure of silk fibroin is indicated by the amide groups of the silk 
proteins, and the positions of amide bands from FTIR spectra are used to determine 
random coil and β-sheet conformation of silk fibroin [77, 78].  
Amide I, amide II and amide III bands, which are characteristics bands of peptide 
groups, were reported to appear at 1630 cm
-1
, 1530 cm
-1
 and 1260 cm
-1
 for 
crystalline β-sheet structure, respectively. The bands at 1660 cm-1, 1540 cm-1 and 
1230 cm
-1
 that determine the amide I, amide II and amide III bands, respectively, are 
specific to the random coil form or silk I [79].  
The F3-G1 scaffolds that were treated with methanol showed absorption bands at 
1623 cm
-1
 (amide I), 1515 cm
-1
 (amide II) and 1233 cm
-1
 (amide III), whereas the F3-
G1 scaffolds without methanol treatment provided absorption peaks at 1634 cm
-1
 
(amide I), 1516 cm
-1
 (amide II) and 1235 cm
-1
 (amide III) (Figure 3.2). Therefore, it 
can be concluded that the absorption peaks of amide II and amide III bands remained 
almost unchanged and the absorption peak of amide I band was shifted to lower 
wave length in case of methanol treatment that may be resulted from β-sheet 
formation.   
The F2-G2 scaffolds that were not treated with methanol showed absorption bands at 
1636 cm
-1
 (amide I), 1527 cm
-1
 (amide II) and 1236 cm
-1
 (amide III), whereas the 
absorption peaks were obtained at 1625 cm
-1
 (amide I), 1516 cm
-1
 (amide II) and 
1235 cm
-1
 (amide III) after the methanol treatment (Figure 3.3). Therefore, it can be 
concluded that the absorption peak of amide III band remained almost unchanged 
and the absorption peaks of amide I and amide II bonds was shifted to lower wave 
lengths in case of methanol treatment that may be resulted from β-sheet formation.   
The F1-G3 scaffolds that were not treated with methanol showed absorption bands at 
1631 cm
-1
 (amide I), 1532 cm
-1
 (amide II) and 1236 cm
-1
 (amide III). No significant 
change was obtained afther the methanol treatment and the absorption peaks were 
recorded as 1629 cm
-1
 (amide I), 1532 cm
-1
 (amide II) and 1235 cm
-1
 (amide III) 
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(Figure 3.4). Based on these data, it can be concluded that the F1-G3 composite 
scaffolds did not show any β-sheet formation. 
Baimark et. al. [78] examined the effect of methanol treatment on random coil and β-
sheet coformations of silk fibroin matrices. According to their results, the absorption 
bands of silk fibroin microparticles without methanol treatment were shown at 1655 
cm
-1
 (amide I) and 1559 cm
-1
 (amide II), which were shifted to 1623 cm
-1
 (amide I) 
and 1530 cm
-1
 (amide II) in case of methanol treatment. These changes were 
attributed to predominant β-sheet conformation in methanol-treated silk fibroin 
microparticles.  
In our study, however, methanol treatment did not cause significant changes in the 
chemical structure of F1-G3 scaffolds but there was a significant shift for F3-G1 and 
F2-G2 samples. In order to obtain β-sheet formation on the scaffolds, the duration of 
methanol treatment can be elongated. Additionally, the amount of methanol used can 
be reconsidered and utilised in higher amounts.  
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Figure 3.2: Comperative FTIR spectra of F3-G1 samples: The black line indicates the sample with methanol treatment, whereas the red line 
indicated the sample without methanol treatment.  
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Figure 3.3: Comperative FTIR spectra of F2-G2 samples: The red line indicates the sample with methanol treatment, whereas the black line 
indicated the sample without methanol treatment.  
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Figure 3.4: Comperative FTIR spectra of F1-G3 samples: The red line indicates the sample with methanol treatment, whereas the black line 
indicated the sample without methanol treatment.  
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3.2 Water-uptake and 3-day in vitro Biodegradation Analysis of Scaffolds 
The results of 3-day in vitro biodegradation tests of F3-G1, F2-G2 and F1-G3 
showed comparable differences (Table 3.1). Increasing gelatin ratio in blend 
solutions resulted in increased degradation rate at the same enzyme concentration. 
For samples treated with 0.05 U/mL Protease XIV, the average percentage of 
remaining weight after the 3
rd
 day was 70% for F3-G1 scaffolds, where it was 65% 
and 18% for F2-G2 and F1-G3, respectively. The average remaining weight ratio of 
all samples showed a decreasing profile as the enzyme concentration was increased 
from 0.05 U/mL to 0.2 U/mL. Thus, F3-G1 with the lowest gelatin ratio showed less 
degradation after the 3
th
 day of the tests. As a result, the enzyme concentration of 
0.05 U/mL was selected for the 4-week in vitro biodegradation test since higher 
concentrations caused rapid and undesired degradation profile when a three-day 
period was taken into consideration.  
Table 3.1: Results of water-uptake and 3-day in vitro biodegradation tests. 
Scaffold 
Type 
Water-
uptake 
(%) 
Remaining weight after biodegradation (%) 
Treatment with 
0.05 U/mL 
enzyme solution 
Treatment with 
0.1 U/mL 
enzyme solution 
Treatment with 
0.2 U/mL 
enzyme solution 
F3-G1 (1) 873 74 63 42 
F3-G1 (2) 648 66 63 77 
F3-G1 (3) 869 71 68 68 
Average 797105 703.3 652.4 6214.8 
Control - 89 
F2-G2 (1) 1386 64 65 37 
F2-G2 (2) 1286 66 60 54 
F2-G2 (3) 1141 64 64 36 
Average 1271100 650.9 632.2 428.3 
Control - 75 
F1-G3 (1) 871 21 2 5 
F1-G3 (2) 1199 13 11 4 
F1-G3 (3) 1090 19 27 2 
Average 1053136 183.4 1310.3 41.2 
Control - 23 
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The effect of blending ratio was studied by several scientists. However, there was no 
article found in the literature that compared the effect of different enzyme 
concentrations on in vitro biodegradation profiles of silk fibroin-gelatin composite 
scaffolds. For this purpose, Jetbumpenkul et. al. immersed different samples in 1 
U/mL collagenase enzyme, incubated them under the conditions applied in this 
study, and observed that the degradation rate rapidly increased as the gelatin ratio in 
silk fibroin-composite scaffolds was increased. After 72 hours, the remaining weight 
percentages of silk fibroin, silk fibroin-gelatin scaffolds with equal polymer ratio, 
and gelatin scaffolds were around 95%, 35% and 0%, respectively. 70% and 5% of 
samples containing 80% silk fibroin and 20% gelatin, and 20% silk fibroin and 80% 
gelatin, respectively, remained at the end of the 72-hour period [7]. Although the 
type and concentration of enzyme solution and degradation rates of samples from the 
given reference study were different than those from this study, both could show that 
increasing gelatin concentration in silk fibroin-gelatin composite scaffolds led to an 
accelerated biodegradation. 
The water-uptake properties of F3-G1, F2-G2 and F1-G3 samples displayed a 
different profile. The average water-uptake ratio of F3-G1 samples was 
approximately 797%, whereas 1271% and 1053% water-uptake ratios were observed 
for F2-G2 and F1-G3 samples, respectively. Among other two types of scaffolds, F2-
G2 samples with equal silk fibroin and gelatin content had the highest water-uptake 
capacity at the end of a 1-day water-uptake period (Table 3.1). 
Lerdchai et. al. also studied on silk fibroin-gelatin composite scaffolds immersed in 
PBS with pH 7.4 at 37 
o
C for 24 hours. Their results showed that the percentage of 
samples with equal silk fibroin and gelatin contents was 710%, whereas the highest 
percentage was observed for samples consisting of 15% silk fibroin and 85% gelatin 
polymers. The overall absorprtion percentages were around 706-732%, and there was 
no significant differences between all groups [75]. Unfortunately, all other 
publications contained different methods and polymers for water-uptake tests that 
disabled a reasonable comparison and conclusion for the effect of type and ratio of 
polymers on absorption pattern of silk fibroin-gelatin scaffolds.   
Based on the results obtained from 3-day in vitro biodegradation test, the enzyme 
concentration of 0.05 U/mL and scaffold samples of F3-G1 and F2-G2 were chosen 
for further evaluation in the main biodegradation and biominerlisation tests. 
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3.3 in vitro Biodegradation Analysis of Scaffolds 
3.3.1 Weight loss during the biodegradation analysis 
The results of in vitro biodegradation tests for F3-G1 and F2-G2 samples showed 
comparable differences between each other after the pre-determined time periods of 
one week, two weeks, three weeks and four weeks.  
For F3-G1 samples, the remaining weight ratio of samples showed a decreasing 
degradation profile throughout the whole process. Only exception for the 4-week 
period was the results obtained after the 3
rd
 week due to unexpected degradation ratio 
for both one of the three degradation samples tested and the control sample. At the 
end of the test, the average percentage of remaining sample weight was 50%, 
whereas 69% of the control sample remained undegraded (Table 3.2). On the other 
hand, the biodegradation profile of F2-G2 samples showed a more steady 
degradation profile compared to that of F3-G1 samples. Degradation rate, however, 
seemed to decrease after the first week. At the end of the test period, the average 
percentage of remaining sample weight was 42%, whereas this value was 73% for 
the control sample (Table 3.2). In comparison with those of F3-G1, the F2-G2 
samples showed a more rapid degradation rate during the first week of the test. The 
average remaining weight percentage at the end of the 1
st
 week was 81% and 60% 
for F3-G1 and F2-G2 samples, respectively. At the end of the 2
nd
 week, samples 
from both scaffold groups exhibited almost the same degradation rate (44% for F3-
G1 samples and 42% for F2-G2 samples). A comparative analysis of biodegradation 
profile observed in both groups was given in Figure 3.5.  
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Table 3.2: Results of in vitro biodegradation tests for a) F3-G1 samples and b) F2-G2 samples. 
 
1
st
 week 2
nd
 week 3
rd
 week 4
th
 week 
Remaining 
Weight
a
 
(%) 
Remaining 
Weight
b
 
(%) 
Remaining 
Weight
a
 
(%) 
Remaining 
Weight
b
 
(%) 
Remaining 
Weight
a
 
(%) 
Remaining 
Weight
b
 
(%) 
Remaining 
Weight
a
 
(%) 
Remaining 
Weight
b
 
(%) 
1
st 
sample 
88 61 71 62 50 63 48 43 
2
nd
 
sample 
83 60 50 57 44 48 53 37 
3
rd
 
sample 
71 60 48 54 26 35 49 45 
Average 
(%) 
817.1 600.5 5610.4 583.3 4010.2 4911.4 502.2 423.4 
Control 
sample 
99 76 94 76 56 74 69 73 
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Figure 3.5: Comparative biodegradation results of F3-G1 and F2-G2 samples. 
As previously stated, several researchers examined the impact of polymer ratios in 
silk fibroin-gelatin composite scaffolds on in vitro biodegradation behaviour. For 
example, Lerdchai et. al. performed a 28-day biodegradation test for silk fibroin-
gelatin constructs with various polymer blending ratios including 100/0, 80/20, 
50/50, 20/80 and 0/100 of silk fibroin and gelatin, respectively. They incubated silk 
fibroin-gelatin sponges in 1U/mL collagenase solution (pH 7.4) containing 0.01% 
(w/v) sodium azide at 37 
o
C. According to their results, the degradation profiles of all 
sponges were similar during the first 8 days. However, the remaining weight of 
gelatin sponges at the end of the test was lower than those of other sponges, 
indicating that gelatin had the highest biodegradation rate (>30%). On the other 
hand, the lowest and highest degradation rates of silk fibroin-gelatin sponges were 
10% and 20%, respectively [75].   
The difference observed in biodegradation profiles of samples comprising the same 
polymers in different ratios may be a result of structural changes that emerged due to 
the interactions between silk fibroin and gelatin polymers. The results indicated that 
the degradation rate and profile of silk fibroin-gelatin composite scaffolds can be 
controlled by adjusting the polymer blending ratios. Due to limited number of studies 
that conducted the biodegradation rate in the same way with this study, additional 
comprehensive assessments could not be done. Another reason for the difference in 
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biodegradation profiles may be the restricted protease enzyme accessibility within 
the scaffolds because of the methanol treatment and glutaraldehyde presence in the 
samples. 
3.3.2 Morphology change during the biodegradation analysis 
SEM images for F3-G1 and F2-G2 samples were taken after the in vitro 
biodegradation assays. The 4-week biodegradation test increased the porous 
properties of some of the F3-G1 and F2-G2 samples (Figure 3.6, Figure 3.7) and led 
to more porous scaffold surfaces. According to the SEM images, the F3-G1 samples 
of the 3
rd
 and the 4
th
 weeks and the F2-G2 sample of the 2
nd
 week did not show any 
significant change in terms of porous morphology.  
 
 
 
  
Figure 3.6: SEM images of F3-G1 samples after the 1
st
 (a), 2
nd
 (b), 3
rd
 (c) and 4
th
 
week of in vitro biodegradation test. 
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Figure 3.7: SEM images of F2-G2 samples after the 1
st
 (a), 2
nd
 (b), 3
rd
 (c) and 4
th
 
week of in vitro biodegradation test. 
3.4 in vitro Biomineralisation  Analysis of Scaffolds 
in vitro biomineralisation test that was described in Section 2.2.7 was performed in 
order to induce hydroxyapatite crystal formation on scaffold surfaces. The presence 
of hydroxyapatite crystals were determined by scanning electron microscopy and 
fourier transform infrared spectroscopy. The SEM images were taken at 
approximately 230x magnification, whereas the FTIR spectra of scaffolds with and 
without mSBF treatment were compared. 
3.4.1 Scanning electron microscopy analysis 
The SEM images of F3-G1 scaffolds that were immersed in either 1x and or 3x 
mSBF solutions were given in Figure 3.8 and Figure 3.9, respectively. However, 
hydroxyapatite formation could only be seen in F3-G1 scaffolds at the end of the 1
st
 
day of the test with 1x mSBF that was indicated with red circles in Figure 3.8a. This 
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may be resulted from damaged overall shape of the samples that prevented distinct 
sample imaging or the magnification level of SEM images.  
 
 
Figure 3.8: SEM images of F3-G1 samples after the 1
st
 (a), 4
th
 (b) and 7
th
 (c) days of 
in vitro biomineralisation test with 1x mSBF. 
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Figure 3.8 (continued): SEM images of F3-G1 samples after the 1
st
 (a), 4
th
 (b) and 
7
th
 (c) days of in vitro biomineralisation test with 1x mSBF. 
 
Figure 3.9: SEM images of F3-G1 samples after the 1
st
 (a), 4
th
 (b) and 7
th
 (c) days of 
in vitro biomineralisation test with 3x mSBF. 
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Figure 3.9 (continued): SEM images of F3-G1 samples after the 1
st
 (a), 4
th
 (b) and 
7
th
 (c) days of in vitro biomineralisation test with 3x mSBF. 
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The SEM images of F2-G2 scaffolds that were immersed either in 1x and or in 3x 
mSBF solutions were given in Figure 3.10 and Figure 3.11, respectively and 
hydroxyapatite crystals were indicated with red circles in Figure 3.10a, 3.10c, 3.11a 
and 3.11c, which corresponds to 1
st
 and 7
th
 weeks for 1X and 3X mSBF samples.  
However, hydroxyapatite formation could not be observed on the samples collected 
at day of 4. This may be resulted from damaged overall shape of the samples that 
prevented distinct sample imaging. As a result, FTIR spectra were compared and 
assessed to detect any possible hydroxyapatite formation for all samples.   
 
Figure 3.10: SEM images of F2-G2 samples after the 1
st
 (a), 4
th
 (b) and 7
th
 (c) days 
of in vitro biomineralisation test with 1x mSBF. 
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Figure 3.10 (continued): SEM images of F2-G2 samples after the 1
st
 (a), 4
th
 (b) and 
7
th
 (c) days  of in vitro biomineralisation test with 1x mSBF. 
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Figure 3.11: SEM images of F2-G2 samples after the 1
st
 (a), 4
th
 (b) and 7
th
 (c) days 
of in vitro biomineralisation test with 3x mSBF. 
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Figure 3.11 (continued): SEM images of F2-G2 samples after the 1
st
 (a), 4
th
 (b) and 
7
th
 (c) days  of in vitro biomineralisation test with 3x mSBF. 
3.4.2 Fourier transform infrared spectroscopy analysis 
Berzina-Cimdina et. al. reported that the most characteristic chemical groups in FTIR 
spectra of synthesised hydroxyapatites are PO4
3-
, OH
-
, CO3
2-
, and HPO4
2-
, which 
were reported by many researchers to form absorption peaks at different wave 
lengths (Table 3.3) [80]. 
Table 3.3: FTIR absorption bands of synthesised hydroxyapatite chemical groups. 
Chemical group Absorption bands (cm
-1
) Description 
PO4
3-
 
460; 560-600; 960; 1020-
1120; 1040; 1000-1100 
Intensive absorption bands at 560, 
600 and 1000-1100 cm
-1
 
OH
-
 
3500; 630 and 3540; 3570 
and 3420; 1650 
OH
-
 ions that prove presence of 
hydroxyapatites. 
CO3
2-
 
873; 1450; 1640; 1650; 
870 and 880; 1460 and 
1530 
Weak peaks between 870 and 880 
cm
-1
; more intensive peaks 
between 1460 and 1530 cm
-1
 
HPO4
2-
 875; 880 
HPO4
2-
 characterises calcium-
deficient hydroxapatite crystals. 
The F3-G1 scaffolds that were immersed in 1x mSBF started to show absorption 
peaks at approximately 1170 cm
-1
 after the 1
st
 day. In addition, a new absorption 
peak at approximately 1040 cm
-1
 was emerged in all samples that were treated with 
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1x mSBF. Both of these absorption peaks were most intensively seen at the end of 
the 7
th
 day (Figure 3.12).  
For F3-G1 scaffold that was immersed in 3x mSBF, a similar pattern was observed. 
There was a new absorption peak at 1170 and 1040 cm
-1
 beginning from the 1
st
 day. 
Both of these absorption peaks were most intensively seen at the end of the 4
th
 and 
7
th
 days (Figure 3.13). 
Based on the information and data given above, for all of the F3-G1 samples, the 
absorption peaks at approximately 1170 cm
-1
 as well as the ones at 1040 cm
-1
 could 
be attributed to the presence of the PO4
3-
 groups on the surface, hence 
biomineralisation. 
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Figure 3.12: Comparative FTIR spectra of F3-G1 samples without (b) and after the 1
st
 (c), 4
th
 (d) and 7
th
 (a) days in biomineralisation test with 
1x mSBF. 
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Figure 3.13: Comparative FTIR spectra of F3-G1 samples without (d) and after the 1
st
 (b), 4
th
 (c) and 7
th
 (a) days in biomineralisation test with 
3x mSBF.  
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As previously explained for the FTIR spectra of F3-G1 scaffolds, the most 
characteristic chemical groups in FTIR spectra of synthesised hydroxyapatites are 
PO4
3-
, OH
-
, CO3
2-
, and HPO4
2-
, and the wave lengths at which they form absorption 
peaks were already given in Table 3.3. 
The F2-G2 scaffolds that were immersed in 1x mSBF showed weak absorption peaks 
at approximately 1040 cm
-1
 beginning from the 1
st
 day. The sample that was 
collected at the of the 7
th
 day showed an additional weak absorption peak at 1206 cm
-
1
 and many weak absorption weaks between 1049 and 767 cm
-1
, with the most 
intensive one at 879 cm
-1
, which may be formed due to the presence of the CO3
2-
 
group (Figure 3.14). 
The absorption peak at 1235 cm
-1
 of the untreated F2-G2 scaffold was shifted to 
1232, 1221 and 1173 cm
-1
 for the 1
st
, 4
th
 and 7
th
 day samples, respectively, after it 
was immersed in 3x mSBF. Another absorption peak that was formed for the sample 
without mSBF-treatment at 1078 cm
-1
 was also shifted to 1037 cm
-1
 at the end of the 
1
st
 and 4
th
 days and to 1039 cm
-1
 at the end of the 7
th
 day. The absorption peaks at 
1173 and 1039 cm
-1
 for the 7
th
 day sample showed more intensive bands than their 
equivalent peaks that were seen in other samples (Figure 3.15). 
According to the FTIR spectra and data of the F2-G2 scaffolds, the absorption peaks 
at 1040 and 1049 cm
-1
 for the samples that were treated with 1x mSBF may be 
resulted from the PO4
3-
 groups. For the sample that were treated with 3x mSBF for 
the 7
th
 day, the absorption peak at 1173 cm
-1
 may also be formed because of the 
presence of the PO4
3-
 groups. The absorption bands at approximately 1037 cm
-1
 that 
were seen in samples immersed in 3x mSBF probably showed the formation of the 
PO4
3-
 groups.   
Composite scaffolds comprising different polymers and hydroxyapatite crystals were 
studied by several scientists. However, there was no article found in the literature 
that was focused on the hydroxyapatite formation on silk fibroin-gelatin composite 
scaffolds. Cholas et. al. incorporated hydroxyapatite microspheres into collagen 
scaffolds with interconnected porosity and showed phosphoric groups at 1025 and 
1047 cm
-1
 and CO3 bands at 1445, 1414 and 876 cm
-1
 according to the FTIR spectra 
of their samples [81]. In a recent study, Tsiourvas et. al. aimed to develop porous 
chitosan scaffolds with high nano-hydroxyapatite content and examined the FTIR 
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spectra of hydroxyapatite-chitosan scaffolds and showed absorption bands at 1090, 
1044, 1019 and 962 cm
-1
 that were assigned to the phosphate groups [82]. In another 
study, Sharma et. al. fabricated a composite scaffold from chitosan, gelatin, alginate 
and nano-hydroxyapatite with the aim of producing a biomimetic construct for bone 
tissue engineering applications. In the FTIR spectra they obtained in their study, 
nano-hydroxyapatite molecules formed a peak at 1030, 604 and 563 cm
-1
 that were 
attributed to the PO4
3-
 stretching and bending vibrations [83]. 
According to the all data from the study and information adapted from references, it 
can be concluded that in vitro biomineralisation tests of F3-G1 and F2-G2 scaffolds 
led to hydroxyapatite formation on scaffold surfaces to some extent that could not be 
easily observed by SEM, but some characteristic absorption peaks could be clearly 
detected in the FTIR spectra of the samples.  
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Figure 3.14: Comparative FTIR spectra of F2-G2 samples without (b) and after the 1
st
 (c), 4
th
 (d) and 7
th
 (a) days in biomineralisation test with 
1x mSBF.  
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Figure 3.15: Comparative FTIR spectra of F2-G2 samples without (a) and after the 1
st
 (b), 4
th
 (c) and 7
th
 (d) days in biomineralisation test with 
3x mSBF.  
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4.  CONCLUSIONS AND RECOMMENDATIONS 
Chemical, biological, mechanical and structural properties of scaffolds and the type 
of the biomaterials that are used to fabricate these biomimetic constructs are essential 
factors for successful tissue engineering applications. The aim of this study was to 
fabricate biocompatible and biodegradable 3D scaffolds for bone tissue engineering 
applications with desired tissue-specific features. To do this, silk fibroin that was 
extracted from Bombyx mori silkworm cocoons and gelatin that was commercially 
purchased were used in different blending ratios as the natural components of the 
composite scaffolds. Glutaraldehyde and methanol were additionally incorporated to 
the blend solutions as chemical agents that led to cross-linked gelatin polymers and 
silk fibroin polymers with β-sheet structures, respectively. The composite scaffolds 
with 100/0, 75/25, 50/50, 25/75 and 0/100 blending ratios were named as F4-G0, F3-
G1, F2-G2, F1-G3 and F0-G4, respectively, and their morphologies were examined 
by Scanning Electron Microscopy (SEM). 
The SEM images showed that increased gelatin ratio in silk fibroin-gelatin composite 
scaffolds resulted in more porous scaffold structures. According to the FTIR spectra 
of these scaffolds, methanol treatment induced β-sheet formation in samples with 
higher fibroin content (F3-G1 and F2-G2). 
Based on the data obtained from the 3-day and 28-day biodegradation studies, the 
average remaining weight percentage was lower for composite scaffolds with higher 
gelatin ratio at the end of both tests, indicating that increased gelatin ratio led to more 
erosion in the composite scaffolds. However, there was no direct correlation between 
gelatin ratio and water-uptake capacity of the scaffolds. On the other hand, 
biodegraded samples showed more porous structures to some extent when compared 
with their equivalents before the test. 
Hydroxyapatite crystals were clearly observed in most of the samples with higher 
gelatin contents. However, the samples treated with mSBF of lower concentration 
exhibited more crystals than those treated with higher concentration mSBF. 
62 
 
Regardsless of the mSBF concentration used, the SEM images of the scaffolds with 
lower gelatin contents showed hydroxyapatite formation in only one sample. Some 
hydroxyapatite-specific absorption bands could be detected in the FTIR spectra of all 
samples. 
In conclusion, the gelatin content directly affected the morphology and 
biodegradation profiles of silk fibroin-gelatin composite scaffolds, indicating that the 
porosity and biodegradation duration and course can be controlled by adjusting 
gelatin ratios in the samples. The number and intensity of the absorption bands that 
are specific to hydroxyapatite crystals were higher for the samples with high gelatin 
content. On the other hand, gelatin did not have a significant impact on the water-
uptake capacity of the scaffolds. 
For future prospects, the composite scaffolds that were produced in this study can be 
further studied and evaluated by peptide immobilisation and cell culture tests in order 
to investigate their potential for bone tissue engineering applications. Once these 
tests exhibit positive results, in vivo experiments can be performed by using animal 
models to show applicability of the whole system consisting of scaffold, seeded cells 
and biological molecules to human. The scaffold composition, polymer blending 
ratios, amount of chemical agents, parametres of lyophilisation, water-uptake, 
biodegradation and biomineralisation tests can be rearranged in order to assess and 
improve the outcomes of this study.  
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APPENDIX A 
Chemical/Material Supplier 
Methanol, CH3OH Sigma-Aldrich 
Gelatin from bovine skin, Type B Sigma-Aldrich 
Glutaraldehyde Sigma-Aldrich 
Sodium azide, NaN3 Merck Millipore 
Silkworm cocoons Kozabirlik  
Sodium chloride, NaCl Merck Millipore 
Potassium chloride, KCl Sigma-Aldrich 
Sodium phosphate dibasic, Na2HPO4 Sigma-Aldrich 
Potassium phosphate monobasic, KH2PO4 Sigma-Aldrich 
Lithium bromide, LiBr Sigma-Aldrich 
Di-potassium hydrogen phosphate, HK2O4P Sigma-Aldrich 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid Biomatik 
Magnesium chloride, Cl2Mg Sigma-Aldrich 
Sodium sulphate, Na2SO4 Sigma-Aldrich 
Sodium bicarbonate, CHNaO3 Sigma-Aldrich 
Calcium chloride, CaCl2 Sigma-Aldrich 
Sodium carbonate, Na2CO3 Sigma-Aldrich 
Hydrochloride, HCl Sigma-Aldrich 
Sodium hydroxide, NaOH Sigma-Aldrich 
Protease XIV Sigma-Aldrich 
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APPENDIX B 
1. The following materials were weighed in the amount mentioned below and 
dissolved in 800 mL ultrapure water: 
 8 g of sodium chloride (NaCl) 
 0.2 g of potassium chloride (KCl) 
 1.44 g of sodium phosphate dibasic (Na2HPO4) 
 0.24 g of potassium phosphate monobasic (KH2PO4) 
2. The pH of the solution was adjusted to 7.4 with hydrochloride (HCl). 
3. The total volume of the solution was adjusted to 1 litre with ultrapure water. 
4. The solution was sterilised by filtration. 
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APPENDIX C 
1. All apparatus to be used for preparation of mSBF solution were washed with 
1.0 M of HCl and ultrapure water. 
2. 700 mL of ultrapure water were poured into a 1 litre polypropylene beaker 
that was stirred using a magnetic bar at room temperature. 
3. The reagents listed below were added according to the order and amounts 
given in the list and completely dissolved. The HEPES was previously 
dissolved in 100 mL of aqueous 0.2 M NaOH.  
1. NaCl: 5.403 g 
2. NaHCO3: 0.504 g 
3. Na2CO3: 0.426 g 
4. KCl: 0.225 g 
5. K2HPO4.3H2O: 0.230 g 
6. MgCl2.6H2O: 0.311 g 
7. HEPES: 17.892 g 
8. CaCl2: 0.293 g 
9. Na2SO4: 0.072 g 
10. NaOH (1.0 M): 15 mL 
4. The fluid was adjusted to a final pH of 7.4 at room temperature by titrating 
aqueous 1.0 M of HCl into the fluid. 
5. The total volume of the fluid was adjusted to 1 litre by adding ultrapure 
water.  
6. The freshly prepared mSBF solution was sterilised by using 0.22 pore size 
filters. 
7. The solution was stored at 4 oC until biomineralisation  assays. 
 
In order to prepare a 3X mSBF solution, the amounts of the ingredients above were 
multiplied by 3. All remaining steps were applied in the same way. 
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APPENDIX D 
Equipment Supplier 
Refrigerator, +4 
o
C Vestel 
Magnetic stirrer Cole-Parmer 
Scale Precisa Gravimetrics AG 
Freezer, -20 
o
C Arçelik 
Freeze-dryer Martin Christ 
pH metre WTW GmbH 
Rocking platform shaker Heidolph Instruments 
Heating/Drying oven Memmert GmbH + Co. KG 
Centrifuge  Beckman Coulter 
Pipettes Eppendorf 
Beakers ISOLAB 
Tissue culture test plates TPP Techno Plastic Products AG 
Scanning electron microscope, SEM FEI 
Dialysis cassettes Thermo Scientific 
Syringe and needle BD Medical 
Ultrapure water system TKA-Pacific 
Fourier transform infrared spectroscopy, FTIR Perkin Elmer 
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